ABOS EFFECT: Shelf registration
Acumen Pharmaceuticals
Filed with the SEC on · accession 9999999995-26-003366
ABOS filed a EFFECT (effect) with the SEC on Oct 28, 2026. Acumen Pharmaceuticals filed an EFFECT notice indicating that a registration statement has been declared effective by the SEC. The stock moved +5.3% by the first close after the filing.
Summary of the filing
Acumen Pharmaceuticals filed an EFFECT notice indicating that a registration statement has been declared effective by the SEC. This typically relates to a shelf registration or other securities offering becoming effective.
Key details
How ABOS stock reacted
Close before
$2.26
Oct 27, 2026
First close after
+5.31%
$2.38
5 trading days
-89.63%
$0.23
Since filing
-90.48%
$0.22
✦ Ask GOAX AI about this filing — what it means for ABOS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ABOS?
Click hereFrequently asked questions
What did ABOS file with the SEC on Oct 28, 2026?
ABOS filed a EFFECT (Shelf registration). Acumen Pharmaceuticals filed an EFFECT notice indicating that a registration statement has been declared effective by the SEC. This typically relates to a shelf registration or other securities offering becoming effective.
What does a shelf registration mean for ABOS stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a EFFECT?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A EFFECT (effect): A report the company filed with the SEC (the US market regulator).
How did ABOS stock react to this filing?
ABOS closed at $2.26 before the filing and $2.38 on Oct 28, 2026 (+5.31%). Five trading days later: $0.23 (-89.63%).
Other ABOS SEC filings
- 8-K · SEC filingNov 5, 2026
- 8-K · Fda rejectionOct 30, 2026
- 10-Q · SEC filingOct 26, 2026
- 8-K · SEC filingOct 26, 2026
- S-3 · Shelf registrationOct 26, 2026
- 8-K · SEC filingSep 16, 2026
- 8-K · SEC filingAug 12, 2026
- 10-Q · SEC filingAug 12, 2026
- 144 · Insider sale plannedJun 17, 2026
- 8-K · SEC filingJun 16, 2026
Get alerts when ABOS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days